PuSH - Publication Server of Helmholtz Zentrum München

Ahmed, A.T.* ; Dehkordi, S.M.* ; Bhattacharyya, S.* ; Arnold, M. ; Louie, G.* ; Dunlop, B.* ; Wang, L.* ; Weinshilboum, R.* ; Krishnan, R.* ; Bobo, W.V.* ; Posse, P.R.* ; Craighead, W.E.* ; McDonald, W.* ; Skime, M.K.* ; Rush, A.J.* ; Frye, M.A.* ; Kaddurah-Daouk, R.*

Short-vs medium plus long-chain plasma acylcarnitine in phenotypes of major depression at baseline and after citalopram/escitalopram treatment.

Biol. Psychiatry 85, S177-S178 (2019)
Open Access Green as soon as Postprint is submitted to ZB.
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Meeting abstract
Keywords Metabolomics ; Major Depressive Disorder (mdd) ; Ssri ; Acylcarnitines ; Phenotype
Language english
Publication Year 2019
HGF-reported in Year 2019
ISSN (print) / ISBN 0006-3223
e-ISSN 1873-2402
Quellenangaben Volume: 85, Issue: 10, Pages: S177-S178 Article Number: , Supplement: ,
Publisher Elsevier
Publishing Place Ste 800, 230 Park Ave, New York, Ny 10169 Usa
Reviewing status Peer reviewed
POF-Topic(s) 30505 - New Technologies for Biomedical Discoveries
Research field(s) Enabling and Novel Technologies
PSP Element(s) G-503700-001
Erfassungsdatum 2019-07-22